fb tracking

Testimony to the FDA’s Advisory Committee on Reproductive Health Drugs on gabapentin for menopausal symptoms

View as PDF.

View press release

Public Citizen strongly opposes the Food and Drug Administration’s(FDA’s) approval of gabapentin for treatment of menopause-related vasomotorsymptoms (VMS, which includes hot flashes and flushing) due to the drug’squestionable benefits and well-established risks.